Common barriers and facilitators to the implementation of digital medicine in chronic respiratory diseases: a systematic review of reviews
Authors:
Open Access
- 26 October 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Digital Health
- Vol. 8, 1927835
Abstract
Background and research question: Digital Medicine offers significant potential for improving care in Respiratory Medicine, yet its full uptake remains limited. Barriers and facilitators involve multiple stakeholders and are likely shared across diseases and technologies. This study had the following research question: What are the common barriers, facilitators, and transferable concepts for implementing Digital Medicine in respiratory diseases, exemplified by bronchial asthma, cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and COVID-19? Study design and methods: Systematic review of reviews. Three electronic databases (PubMed, Scopus, and Web of Science), as well as Cochrane Library were searched for review publications from September 2019 through May 2026. Nine included reviews were appraised using AMSTAR-2. Original publications referenced within these reviews were additionally screened for suitability for data extraction, leading to inclusion of 18 original publications. Extracted barriers and facilitators were visualized as disease- and actor-stratified co-occurrence networks and mapped to two implementation frameworks (CFIR and Chaudoir et al. 2013). Results: No COVID-19 publication met inclusion criteria. Asthma and, partially, CF evidence was rich and included institution-level data, while COPD evidence was less diverse. One CF program survey had structured its data according to the CFIR framework, enabling uniquely complete mapping of barriers and facilitators. Conclusion: High-quality, framework-structured, network-visualizable evidence on barriers and facilitators to Digital Medicine exists in bronchial asthma and, partially, CF. In contrast, evidence on barriers and facilitators in COPD is not yet systematic. Future studies should be anchored in frameworks for sufficient comprehensiveness and facilitated knowledge translation into implementability. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251070944 , PROSPERO, CRD420251070944.Keywords
Funding Information
- Deutsches Zentrum für Lungenforschung
This publication has 44 references indexed in Scilit:
- What is digital health, eHealth, uHealth and Healthcare 4.0?Informatics and Health, 2025
- Telehealth in Cystic Fibrosis. A systematic review incorporating a novel scoring system and expert weighting to identify a ‘top 10 manuscripts’ to inform future best practices implementationJournal of Cystic Fibrosis, 2023
- Barriers and facilitators to the adoption of digital health interventions for COPD management: A scoping reviewHeart & Lung, 2023
- Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factorsJournal of Cystic Fibrosis, 2021
- Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team membersJournal of Cystic Fibrosis, 2021
- Facilitators and Barriers to Implementation of School-Based Telehealth Asthma Care: Program Champion PerspectivesAcademic Pediatrics, 2021
- Learning to breathe with Tai Chi online - qualitative data from a randomized controlled feasibility study of patients with cystic fibrosisEuropean Journal of Integrative Medicine, 2020
- Using the Technology Acceptance Model to conceptualise experiences of the usability and acceptability of a self-management app (COPD.Pal®) for Chronic Obstructive Pulmonary DiseaseHealth and Technology, 2020
- Examining overlap of included studies in meta‐reviews: Guidance for using the corrected covered area indexResearch Synthesis Methods, 2019
- Home visits for uncontrolled asthma among low-income adults with patient portal accessJournal of Allergy and Clinical Immunology, 2019